powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1528448917
Paul Belany
D.O.
Endocrinology
Cincinnati,
OH
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$408
Payment records
14
By payment type
Food and Beverage
$408
Top paying entities
Food and Beverage
$408
QUALITY · MIPS · 2024
Final MIPS score
88.7
Quality
83.1
Cost
79.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.58%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
2,954
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
35
Brand share
70.0%
Top prescribed drugs
Tirzepatide
342 claims
Levothyroxine Sodium
293 claims
Semaglutide
260 claims
Empagliflozin
246 claims
Dulaglutide
112 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
839
Unique beneficiaries
—
Total services
36,751
Distinct HCPCS
11
Medicare payment
$411K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 229 Endocrinology providers in OH — top quintile (cohort median 563).
